Famciclovir and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Famciclovir (famciclovir), especially for people who are female, 2-9 old, also take Ondansetron, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Nosebleed when taking Famciclovir. It is created by eHealthMe based on reports of 3,287 people who have side effects when taking Famciclovir from the FDA, and is updated regularly.

What is Famciclovir?

Famciclovir has active ingredients of famciclovir. It is often used in herpes zoster. eHealthMe is studying from 3,389 Famciclovir users. Check the latest studies of Famciclovir.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.



On Jul, 14, 2026

3,287 people reported to have side effects when taking Famciclovir.
Among them, 37 people (1.13%) have Nosebleed.

Could Famciclovir cause Nosebleed?

Among these 37 people:

What is the gender of people who have Nosebleed when taking Famciclovir? *

  • female: 74.29 %
  • male: 25.71 %

What is the age of people who have Nosebleed when taking Famciclovir? *

  • 0-1: 0.0 %
  • 2-9: 44.12 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 41.18 %
  • 40-49: 0.0 %
  • 50-59: 2.94 %
  • 60+: 11.76 %

What are other drugs people take besides Famciclovir? *

  1. Paracetamol: 16 people, 43.24%
  2. Ondansetron: 16 people, 43.24%
  3. Lemtrada: 13 people, 35.14%
  4. Foscavir: 10 people, 27.03%
  5. Vistide: 10 people, 27.03%
  6. Sulfamethoxazole And Trimethoprim: 8 people, 21.62%
  7. Amlodipine: 6 people, 16.22%
  8. Vancomycin: 6 people, 16.22%
  9. Magnesium: 4 people, 10.81%
  10. Ciclosporin: 4 people, 10.81%

What are other side effects people have besides Nosebleed? *

  1. Aplastic Anemia: 16 people, 43.24%
  2. Chest Pain: 13 people, 35.14%
  3. Headache (pain in head): 13 people, 35.14%
  4. Wheezing (a high-pitched whistling sound made while you breath): 13 people, 35.14%
  5. Dyspnea (difficult or laboured breathing): 13 people, 35.14%
  6. Rash Pruritic (redness with itching): 11 people, 29.73%
  7. Stomatitis (inflammation of mucous membrane of mouth): 11 people, 29.73%
  8. Lip Haemorrhage (bleeding lip): 11 people, 29.73%
  9. Itching: 10 people, 27.03%
  10. Adenovirus Infection: 10 people, 27.03%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 14 people, 37.84%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 6 people, 16.22%
  3. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 5.41%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.70%
  5. Stress And Anxiety: 1 person, 2.70%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.70%
  7. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 2.70%
  8. Multiple Myeloma (cancer of the plasma cells): 1 person, 2.70%
  9. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 2.70%
  10. Hypersensitivity: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Famciclovir and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Famciclovir:

Nosebleed treatments and more:

How severe was Nosebleed and when was it recovered:

Expand to all the drugs that have ingredients of famciclovir:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Famciclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Browse all the conditions that are associated with Nosebleed:


How the study uses the data?

The study uses data from the FDA. It is based on famciclovir (the active ingredients of Famciclovir) and Famciclovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: